Background and Purpose-Endothelin-1 (ET-1) is suggested to be a major cause of cerebral vasospasm after subarachnoid hemorrhage. However, the mechanism of ET-1-induced contraction in cerebral arteries remains unclear. This study was undertaken to demonstrate the possible role of protein tyrosine kinase (PTK), mitogen-activated protein kinase (MAPK), and protein kinase C (PKC) in ET-1-induced contraction. Methods-PD-98059, damnacanthal, wortmannin, AG-490, genistein, calphostin C, and staurosporine were used to inhibit, or relax, the ET-1-induced contraction of basilar artery, studied with an isometric tension system. Immunoprecipitation of MAPK in ET-1-stimultated rings of basilar artery without or with the above inhibitors was studied with Western blot. 
with modified Krebs-Henseleit bicarbonate solution, bubbled with 95% O 2 /5% CO 2 . No attempt was made to remove endothelial cells. The modified Krebs-Henseleit solution contained the following (mmol/L): NaCl 120, KCl 4.5, MgSO 4 1, NaHCO 3 27 , KH 2 PO 4 1, CaCl 2 2.5, and dextrose 10. All procedures were approved by the Animal Care and Use Committee at the University of Mississippi Medical Center.
The rings were suspended at 500 mg resting tension (Radnoti transducer, Radnoti Glass) between stainless steel hooks in 10-mL water-jacketed tissue baths (Radnoti Glass). The tissue bath was filled with modified Krebs-Henseleit buffer and bubbled with 95% O 2 /5% CO 2 at 37°C. Rings were equilibrated for 90 minutes, and the bath solution was changed every 20 minutes. After equilibration, tissues were challenged with KCl (90 mmol/L) 2 times at 30-minute intervals to obtain stable contractions. Only data with recovery of 90% to 110% of the initial contraction by KCl (90 mmol/L) were included. Tension was recorded continuously with a forcedisplacement transducer, as described previously. 2 
Western Blot
The basilar arteries were removed from the base of the brain and incubated with ET-1 (1 mol/L) for 1, 3, 5, 10, 30, 60, and 120 minutes in Krebs-Henseleit buffer. Some arteries were treated with specific antagonists for 30 minutes (see Materials) before being treated with ET-1. After treatment, the arteries were immediately frozen in liquid nitrogen. The arteries were homogenized for 20 minutes at 4°C in the following (mmol/L): Tris-HCl (pH 7.5) 50, NaCl 100, EDTA 5, phenylmethylsulfonyl fluoride 1, and IGEPAL CA-630 100 L. The insoluble materials were removed by centrifugation (13 000g, 10 minutes, 4°C). The samples (30 g protein) were applied to 12.5% SDS-PAGE. After electrophoretic transfer of the separated polypeptides to nitrocellulose membrane, the membranes were blotted with 8% nonfat milk in Tris-buffered PBS for 1 hour. The membranes were washed with Tris-buffered PBS and incubated at 4°C overnight in a 1:5000 dilution of mouse anti-MAPK antibodies (ERK1/ERK2, monoclonal mouse antibody, Zymed Laboratories). These antibodies recognize both phosphorylated and nonphosphorylated MAPK. The nitrocellulose membranes were later washed with Tris-buffered PBS and incubated with a 1:5000 dilution of goat anti-mouse IgG antibody, linked with horseradish peroxidase. The enhanced chemiluminescence system (Amersham) was used for visualization of protein bands. The results were quantified by SigmaGel software (SPSS Inc).
Data Analysis
Data are expressed as meanϮSEM. Statistical differences between the control and other groups were compared by 1-way ANOVA and then Tukey-Kramer multiple comparison procedure (95% CI) if significant variance was found. A value of PϽ0.05 was considered statistically significant.
Results

Effect of ET-1 on Contraction and MAPK Immunoprecipitation
The initial contraction was observed with 10 Ϫ9 mmol/L ET-1, and the maximum contraction was not obtained even at 10 Ϫ6 mmol/L of ET-1 in rabbit basilar artery ( Figure 1 ). Since the maximum contraction to ET-1 was not obtained, we could not calculate the pA 2 values.
Preincubation of the arteries with a selective ET A receptor antagonist BQ-610 (10 Ϫ6 mmol/L) significantly inhibited ET-1-induced contraction ( Figure 1A ). The selective ET B receptor antagonist BQ-788 (10 Ϫ6 mmol/L) was used in the same fashion as BQ-610 but failed to reduce the effect of ET-1 ( Figure 1B) . None of the inhibitors changed the resting tension alone. 
Effect of Inhibitors on ET-1-Induced Contraction
MAPK inhibitors PD-98059 and U-0126 (100 mol/L), preincubated with arteries for 30 minutes, significantly reduced ET-1-induced contraction (Figure 3 ) (PϽ0.005 to PϽ0.001, ANOVA). At a lower concentration (30 mol/L), U-0126 but not PD-98059 produced significant inhibition (PϽ0.05, ANOVA).
The Src tyrosine kinase inhibitor damnacanthal, the phosphatidylinositol-3 kinase (PI-3K) inhibitor wortmannin, and the Janus tyrosine kinase (JAK 2 ) inhibitor AG-490 (30 mol/L) were used in the same manner as MAPK inhibitions and were found to abolish the contractile effect of ET-1 ( Figure 4) .
The PKC inhibitors calphostin C and staurosporine and the PTK inhibitor genistein were tested. Calphostin C inhibits both phorbol ester binding and phosphotransferase activity of the PKC by binding to the regulatory domain at the diacylglycerol/phorbol ester binding site. 3 Staurosporine, a microbial alkaloid, interacts with the catalytic moiety of the PKC. Calphostin C (5ϫ10 Ϫ7 mmol/L) failed to reduce ET-1-induced contraction, while staurosporine (2ϫ10 Ϫ7 mmol/L) completely abolished it (PϽ0.001, ANOVA) ( Figure 5A and 5B). The PTK inhibitor genistein (10 Ϫ4 mmol/L), preincubated for 30 minutes, produced partial inhibition of ET-1-induced contraction (PϽ0.05, ANOVA) ( Figure 5C ).
In another study the rings of rabbit basilar artery were precontracted with ET-1 (10 Ϫ6 mmol/L), and once a stable contraction was obtained, cumulative concentrations of PD-98059, U-0126, AG-490, wortmannin, damnacanthal, genistein (10 Ϫ6 to 10 Ϫ4 mmol/L), and staurosporine (10 Ϫ8 to 2ϫ10 Ϫ7 mmol/L) were applied. All agents fully relaxed the sustained contraction induced by ET-1 (10 Ϫ6 mmol/L) ( Figure  6 ). Calphostin C was not used because it failed to inhibit ET-1-induced contraction ( Figure 5A ).
Effect of Inhibitors on MAPK Immunoprecipitation
Endothelin-1 (10 Ϫ6 mmol/L) produced a time-dependent MAPK immunoprecipitation in rabbit basilar artery. The effect of ET-1 was observed at 3 minutes, peaked between 5 and 30 minutes, decayed at 60 minutes, and was reelevated at 2 to 4 hours ( Figure 7) .
In another study inhibitors were applied for 30 minutes before the arteries were treated with ET-1 (10 Ϫ6 mmol/L, 5 minutes). PD-98059, U-0126, damnacanthal, AG-490 (3ϫ10 Ϫ5 mmol/L), and genistein (10 Ϫ4 mmol/L), but not staurosporine (2ϫ 10 Ϫ7 mmol/L) or wortmannin (3ϫ10 Ϫ5 mmol/L), abolished the effect of ET-1 on MAPK immunoprecipitation ( Figure 8 ).
Discussion
We have demonstrated the following: (1) 
Role of Endothelin in Cerebral Vasospasm
The role of ET-1 in cerebral vasospasm has been studied in the following 4 directions: (1) Elevation of ET-1 was found in bloody cerebrospinal fluid from vasospasm patients. 1 The mean concentration of ET-1 in cerebrospinal fluid obtained from SAH patients was significantly higher than in healthy individuals. 1 Plasma ET-1 concentrations at the onset of SAH in the patients with vasospasm were significantly higher than those of healthy individuals, and the high levels persisted for 3 to 14 days. 1 (2) ET-1 produced a prolonged contraction of cerebral arteries. In isolated middle cerebral arteries of the goat, ET-1 induced Ca 2ϩ -dependent contraction. In addition, the constrictor effect of ET-1 was enhanced after SAH. 4 (3) ET-1 induced vasospasm in animal models. In the canine basilar artery, ET-1 induced dose-dependent angiographic constriction after intracisternal injection. By day 3, the diameter of the basilar artery had diminished to 76% of the value seen in the control group. 5 (4) Endothelin receptor antagonists prevented vasospasm. 1 The nonselective endothelin receptor antagonist bosentan reversed vasospasm in rabbit single-hemorrhage and dog double-hemorrhage models. 6 In the monkey SAH model, BQ-123 (ET A receptor antagonist) effectively prevented cerebral vasospasm. 7 The endothelinconverting enzyme levels increased after SAH, 8 and endothelin-converting enzyme inhibitors also attenuated vasospasm after SAH. 1 Antisense oligonucleotide DNA therapy prevented vasospasm in a canine model. 9 Thus, even though some controversial reports indicate a poor correlation between cerebrospinal fluid endothelin levels and vasospasm 10 and the failure of ET A receptor antagonists to reverse vasospasm, 11 the overall picture supports the indication that ET-1 is a major cause of cerebral vasospasm. 1
Signal Transduction Pathways in ET-1-Induced Contraction
The action of endothelin is mediated by 3 different receptor subtypes: ET A , ET B1 , and ET B2 . The ET A receptor subtype is localized in vascular smooth muscle cells and mediates the vasoconstrictive effect of endothelins. 1 The ET B1 receptor subtype is present in vascular endothelial cells and mediates Ϫ5 mol/L), and AG-490 (3ϫ10 Ϫ5 mol/L) on the ET-1-induced contraction of rabbit basilar arteries. In the control group, the arteries were contracted by exposure to ET-1 (10 Ϫ12 to 10 Ϫ6 mol/L) in the absence of damnacanthal, wortmannin, and AG-490 in the control rings. In the treated group, damnacanthal, wortmannin, and AG-490 were preincubated in separate chambers with arterial rings for 30 minutes before dosedependent contraction with ET-1. All of these antagonists abolished ET-1-induced contraction. n indicates the number of arterial rings studied. *PϽ0.05, ***PϽ0.001 (ANOVA). 
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endothelium-derived relaxation. The ET B2 receptor subtype is located in smooth muscle cells and causes vasoconstriction. 1 Signal transduction pathways after ET-1 stimulation were not studied systematically in cerebral tissues. In peripheral tissues, ET-1 stimulates pp60 c-Src and pp125 focal adhesion kinase activity, resulting in tyrosine phosphorylation of specific cellular proteins. 12 Activation of c-Src by ET-1 might link G-protein-coupled receptors to the primary downstream targets of nonreceptor PTK. Simonson and Herman 13 demonstrated that ET-1 caused a marked increase of the level of immunoreactive tyrosine phosphorylated proteins, suggesting that phosphorylation of PTK is a necessary step in the mitogenic response to ET-1. ET-1 activates small GTP-binding protein p21 ras and increases the p21 ras -associated PI-3K activity. 14 Activation of PKC, PTK, PI-3K, and Ras may lead to the activation of MAPK in a variety of cells. 15 We have demonstrated in this study that ET-1 produced contraction of rabbit basilar artery by activating ET A receptors. Activating ET A receptors (G-protein-coupled receptors) leads to the activation of phospholipase C and the generation of inositol 1,4,5-triphosphate and diacylglycerol. Diacylglycerol in turn theoretically activates PKC. Thus, it is not surprising that the PKC inhibitor staurosporine abolished the contractile effect of ET-1 in this study. Similar findings were reported in rat basilar and middle cerebral arteries in that H-7, another PKC inhibitor, significantly reduced ET-1-induced contraction, indicating that ET-1 produces contractions by activation of PKC. 16 ET-1 induced a transient translocation of PKC activity from the cytosol to the membrane, and staurosporine reduced ET-1-induced contraction in bovine cerebral arteries. 17 The failure of calphostin C in reducing ET-1-induced contraction in this study is actually consistent with some previous reports that staurosporine and H-7 18 but not calphostin C 19 attenuated cerebral vasospasm in animal models. However, because of the discrepancy between the effects of staurosporine and calphostin C in this study, the role of PKC in ET-1-induced contraction in rabbit basilar artery remains unconfirmed and requires further investigation.
The contractile effect of ET-1 was either abolished or attenuated by PTK, PI-3K, JAK 2 , Src, and MAPK inhibitors, indicating that ET-1-induced contraction in rabbit basilar arteries is mediated by multiple signaling pathways. This result differs from our previous observation of hemolysateinduced contraction in rabbit basilar arteries. 2 Hemolysateinduced contraction was attenuated by PTK and MAPK inhibitors 2, 20 but not reduced by PI-3K, Src, or JAK 2 inhibitors, indicating that the signaling pathway for hemolysate is PTK-MAPK. To establish the relationship between MAPK and other signaling pathways, inhibitors for those pathways were tested on ET-1-induced MAPK phosphorylation. ET-1-induced MAPK immunoprecipitation was reduced by all but PKC and PI-3K inhibitors (Figure 8) , suggesting that ET-1-induced contraction was mediated by multiple signal- ing pathways. PTK, Src, and JAK 2 probably mediated ET-1-induced contraction by activating MAPK. It has been established that activation of PTK or Src by receptor agonists may activate Ras, leading to the activation of MAPK in rabbit basilar artery. 15 JAK 2 is required for MAPK activation by some growth hormones, more likely through phosphorylation of Raf-1. 15 Growth hormone receptor/JAK 2 -mediated activation of MAPK (ERK1/ERK2) is dependent on both Ras and Raf-1. 15 AG-490, a specific inhibitor of JAK 2 , prevents proliferation of vascular smooth muscle cells, complex formation of JAK 2 and Raf-1, tyrosine phosphorylation of Raf-1, and thus activation of ERK1 in response to either angiotensin II or platelet-derived growth factor. 21 Even though MAPK and other signaling pathways may be involved in ET-1-induced contraction in rabbit basilar artery, and this observation is supported by isometric tension and Western blot studies, these results should be interpreted carefully because these studies depend heavily on the use of inhibitors. Inhibitors of MAPK or other signaling pathways may possess additional or nonspecific actions, and further studies are needed to clarify the mechanism of ET-1-induced contraction.
PI-3K may be involved in MAPK-independent ET-1-induced contraction in rabbit basilar arteries, since PI-3K inhibitor abolished ET-1-induced contraction but failed to prevent ET-1-induced MAPK immunoprecipitation. The possible involvement of PKC in ET-1-induced contraction is still debatable, but PKC may not be involved in ET-1-induced MAPK immunoprecipitation, since staurosporine but not calphostin C reduced ET-1-induced contraction and staurosporine failed to reduce ET-1-induced MAPK immunoprecipitation. The relationship between PKC and PI-3K in ET-1-induced contraction is not clear. One study indicated that PI-3K seemed downstream of PKC since the PI-3K inhibitor wortmannin inhibited ET-1-induced mitogenic responses in PKC activator PMA-treated and untreated Chinese hamster ovary cells. 22 The role of PI-3K and PKC in ET-1-induced contraction requires further investigation.
Role of PTK, MAPK, and PKC in Cerebral Vasospasm
It has been suggested that PTK regulates intracellular Ca 2ϩ and contraction of cerebral smooth muscle cells. 20 entry from external space. PTK may potentiate the sensitivity of contractile proteins to Ca 2ϩ . 24 The mechanism for MAPKrelated contraction is probably mediated by phosphorylation of thin filament-associated proteins such as caldesmon. 25 The 2 isoforms 42 and 44 kDa (ERK1/ERK2) are the most well-studied MAPK and are activated by dual phosphorylations of the threonine and tyrosine residues. 15 Both PTK and MAPK have been suggested to be involved in cerebral vasospasm. PTK is involved in the regulation of intracellular Ca 2ϩ in cultured endothelial 26 and smooth muscle cells. 23 PTK and MAPK are involved in the contractions of rabbit basilar arteries by hemolysate. 2, 20 MAPK activity was elevated in canine basilar arteries in a double-hemorrhage model of experimental cerebral vasospasm. 27 This study for the first time demonstrated that PTK and MAPK are involved in ET-1-induced contraction in cerebral arteries. Since both hemolysate and ET-1 are extremely important spasmogens for cerebral vasospasm 1,2 and PTK and MAPK are involved in the signal transduction of both hemolysate 2, 20 and ET-1 (this study), PTK and MAPK may be important factors in the pathogenesis of cerebral vasospasm.
It has been suggested that some upstream regulators such as PI-3K, JAK, and Src may be involved in the activation of MAPK. 15 Src family kinases play an important role in relaying signals from both G q -and G i -coupled receptors to MAPK. 28 It was shown that activating one of the proteins in this family, p56 lck , led to a time-dependent activation of phosphotransferase activity of the MAPK in T cells. 28 Angiotensin II stimulation was associated with a rapid activation of c-Src and activation of MAPK in vascular smooth muscle cells. 29 PI-3K activation may be upstream of Ras activation, and PI-3K may be involved in the function of Src, Shc, and Grb2. 30 It has been reported that the p110 subunit of PI-3K binds to an effector domain of Ras in vitro, 30 and the PI-3K inhibitor wortmannin reduced insulin-induced MAPK activity. 31 The JAK 2 family is a key mediator of mRNA expression characterized as "early growth response genes." 32 Recent studies have established that JAK 2 associates with membrane receptors and, when activated, stimulates tyrosine phosphorylation of a family of transcription factors termed signal transducers and activators of transcription (STAT). STAT 
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proteins translocate to the nucleus, where they stimulate transcription of early growth response genes. JAK 2 PTK may represent a common component in the activation of MAPK and STAT signaling pathways, which appear to bifurcate upstream of Ras activation but converge with MAPK phosphorylation. 25 The role of JAK 2 in smooth muscle contraction is unclear, even though activation of 5-HT 2A receptor in skeletal muscles triggers a rapid and transient tyrosine phosphorylation of JAK 2 kinase. On the basis of the data obtained in this study, it is likely that PTK, JAK, and Src are involved in ET-1-induced contraction and MAPK immunoprecipitation in rabbit basilar arteries. PI-3K, if involved in ET-1-induced contraction, seems to mediate the contractile action of ET-1 by other mechanisms, since wortmannin failed to reduce ET-1-induced MAPK immunoprecipitation. These results are also distinct from those observed previously with hemolysate. 2 None of the proteins PI-3K, JAK, and Src were involved in hemolysate-induced contraction of rabbit basilar arteries. PKC and endothelin are 2 important factors in cerebral vasospasm. 1, 33 PKC produces prolonged contraction of cerebral arteries and may lead to contraction by activation of PTK and MAPK. 32 ET-1 produces prolonged contraction, and endothelin receptor antagonists attenuate cerebral vasospasm in animal models. However, the relationship between endothelin and PKC has not been established. This study failed to confirm this relationship because of the discrepancy in the effectiveness of staurosporine and calphostin C in reducing ET-1-induced contraction. This study, on the other hand, pointed out that ET-1-induced contraction seems to be mediated by multiple signaling pathways, and ET-1-induced MAPK immunoprecipitation may be PKC independent. The effect of staurosporine, which reduced the contraction of ET-1 but failed to decrease MAPK immunoprecipitation, offered some evidence of this.
Conclusion
We have demonstrated that the signal transduction pathways for ET-1 in rabbit basilar arteries may involve different proteins, including Src, JAK 2 , PI-3K, PTK, and MAPK. Among them, the Src-JAK 2 -PTK-MAPK pathway seems connected in contraction and activation of MAPK, and MAPK may serve as a final common pathway. PI-3K may be involved in ET-1-induced contraction, although probably by other MAPK-unrelated mechanisms. The role of PKC is uncertain, but it may not be involved in ET-1-induced MAPK immunoprecipitation. The role of these proteins in ET-1-induced contraction and the possible use of these inhibitors in cerebral vasospasm require further investigation.
